English | 繁體

Search in the results

UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Nuclear hkii–p-p53 (Ser15) interaction is a prognostic biomarker for chemoresponsiveness and glycolytic regulation in epithelial ovarian cancer Journal article
Han, Chae Young, Patten, David A., Kim, Se Ik, Lim, Jung Jin, Chan, David W., Siu, Michelle K.Y., Han, Youngjin, Carmona, Euridice, Parks, Robin J., Lee, Cheol, Di, Li Jun, Lu, Zhen, Chan, Karen K.L., Ku, Ja Lok, Macdonald, Elizabeth A., Vanderhyden, Barbara C., Mes-Masson, Anne Marie, Ngan, Hextan Y.S., Cheung, Annie N.Y., Song, Yong Sang, Bast, Robert C., Harper, Mary Ellen, Tsang, Benjamin K.. Nuclear hkii–p-p53 (Ser15) interaction is a prognostic biomarker for chemoresponsiveness and glycolytic regulation in epithelial ovarian cancer[J]. Cancers, 2021, 13(14), 3399.
Authors:  Han, Chae Young;  Patten, David A.;  Kim, Se Ik;  Lim, Jung Jin;  Chan, David W.; et al.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:4.5/4.9 | Submit date：2021/12/08
Cancer Metabolism  Chemoresistance  Epithelial Ovarian Cancer  Hexokinase Ii  P-p53 (Ser15)  
Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations Journal article
Lin G.-W., Xu C., Chen K., Huang H.-Q., Chen J., Song B., Chan J.K.C., Li W., Liu W., Shih L.-Y., Chuang W.-Y., Kim W.S., Tan W., Peng R.-J., Laurensia Y., Cheah D.M.Z., Huang D., Cheng C.L., Su Y.-J., Tan S.-Y., Ng S.-B., Tang T.P.L., Han K., Wang V.Y.-F., Jia W.-H., Pei Z., Li Y.-J., Gao S., Shi Y., Hu Z., Zhang F., Zhang B., Zeng Y.-X., Shen H., He L., Ong C.K., Lim S.T., Chanock S., Kwong Y.-L., Lin D., Rothman N., Khor C.C., Lan Q., Bei J.-X., Au W.-Y., Chiu B., Fan L., Li Z., LAM T.H., Liang R., Yeh S.-P., Xu J., Ip D.K.M., Li G., Xu G., Wang X., Bai O., Cai Q.-Q., Xia Y., Chen J.-R., Luo C.-L., Xiong X.-Y., Zeng Y., Wei P.-P., Liu C.-J., Liu Y.-X., Cao Y.-L., He S., Liu Y., Ha J.C.H., Khoo L.P., Kee R.X., Tan J., Liu Y., Zhang F., Feng Y., Rao H., Chng W.J., Chan J.Y.S., Somasundaram N.D., Tao M., Ras M.F.B.H., Yeoh K.-W., Goh Y.T., Ong S.Y., Grigoropoulos N.F., Wong E.K.Y., Pang J.W.L., Lim J.Q., Chia B.K.H., Kim S.J., Yoon S.E., Choi S., Kuo C.-Y., Chen T.-Y., Su Y.-C., Huang W.-T., Lee M.-Y., Yao W., Ngan K.-C., Liu H., Lee H., Yip S.-F., Liu J., Li J., Rabkin C.S., Berndt S., Bassig B., Hu W., Zhao M., Li Y., Zhai Q., Shao Z., Qiu L., Wang J., Xu F.-P., Chen L., Hou Y., Xu S., Huang Z., Xie M., Li M., Zhong S., Zhang Y., Gu D., Wang X., Foo J.N., Li Z., Dai J., Sun L., Wang Z., Liu H., Zhou H., Sun Y., Koh W.-P., Heng C.-K., Hong C.S., Ahn J., Park K.H., Tin A., Gu J., Xia X., Li B., Yu X., International NKTCL Working Group. Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations[J]. The Lancet Oncology, 2020, 21(2), 306-316.
Authors:  Lin G.-W.;  Xu C.;  Chen K.;  Huang H.-Q.;  Chen J.; et al.
Favorite | TC[WOS]:49 TC[Scopus]:52  IF:41.6/42.2 | Submit date：2022/06/15
Rapid identification of anti-micrometastases drugs using integrated model systems with 2D monolayer, 3D spheroids and zebrafish xenotransplantation tumors Journal article
Fu, A, Peh, YM, Ngan, W, Wei, N, Luo, KQ. Rapid identification of anti-micrometastases drugs using integrated model systems with 2D monolayer, 3D spheroids and zebrafish xenotransplantation tumors[J]. Biotechnology and Bioengineering, 2018, 2828-2843.
Authors:  Fu, A;  Peh, YM;  Ngan, W;  Wei, N;  Luo, KQ
Favorite | TC[WOS]:12 TC[Scopus]:14 | Submit date：2022/08/26
Anti-metastasis Drug Discovery  3d Tumor Spheroids  Zebrafish Xenograft Tumor Model  Fluorescence Resonance Energy Transfer (Fret)  Pi3k/akt Pathway